These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 5712680)

  • 1. [Development of an influenza virus adsorbate-vaccine for use with a jet injector].
    Belian W; Neubert G; Rinka E; Starke G
    Dtsch Gesundheitsw; 1968 Sep; 23(39):1858-60. PubMed ID: 5712680
    [No Abstract]   [Full Text] [Related]  

  • 2. Intranasal versus injectable influenza vaccine.
    Genton B; D'Acremont V
    Clin Infect Dis; 2004 Sep; 39(5):754; author reply 754-5. PubMed ID: 15356796
    [No Abstract]   [Full Text] [Related]  

  • 3. Influenza vaccine programme using the hypospray jet injector method.
    Wright M
    Occup Health (Lond); 1968; 20(5):254-7. PubMed ID: 5188805
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of an adsorbed trivalent split influenza vaccine administered by intradermal route.
    Niculescu IT; Zilişteanu E; Alexandrescu V; Maţepiuc M; Creţescu L; Ionescu N; Molnar G; Răcăşan R; Mogoş A
    Arch Roum Pathol Exp Microbiol; 1981; 40(1):67-70. PubMed ID: 7185350
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pandemic H5N1 influenza vaccine development: an update.
    El Sahly HM; Keitel WA
    Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant.
    Ichinohe T; Watanabe I; Tao E; Ito S; Kawaguchi A; Tamura S; Takahashi H; Sawa H; Moriyama M; Chiba J; Komase K; Suzuki Y; Kurata T; Sata T; Hasegawa H
    J Med Virol; 2006 Jul; 78(7):954-63. PubMed ID: 16721854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza vaccine with squalene adjuvant: new preparation. No better than available products.
    Prescrire Int; 2004 Dec; 13(74):206-8. PubMed ID: 15599987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using surveillance to evaluate influenza vaccine effectiveness.
    Jackson LA
    J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
    [No Abstract]   [Full Text] [Related]  

  • 10. [Formation of humoral antibodies using different vaccination modes with an influenza virus adsorbate vaccine].
    Pechmann HC; Klett G; Willkommen H; Tiller FW; Thilo W
    Z Arztl Fortbild (Jena); 1980 Nov; 74(22):1073-7. PubMed ID: 7233993
    [No Abstract]   [Full Text] [Related]  

  • 11. [Vaccine prophylaxis of influenza].
    Fridman EA; Bichurina MA
    Tr Inst Im Pastera; 1992; 67():45-64. PubMed ID: 8539767
    [No Abstract]   [Full Text] [Related]  

  • 12. An inactivated subvirion influenza A (H5N1) vaccine.
    Focosi D
    N Engl J Med; 2006 Jun; 354(25):2724-5; author reply 2724-5. PubMed ID: 16795150
    [No Abstract]   [Full Text] [Related]  

  • 13. Advances in the prophylaxis and treatment of influenza illness. Based on a presentation by Frederick G. Hayden, MD.
    Am J Manag Care; 2000 Mar; 6(5 Suppl):S247-54. PubMed ID: 10977471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza vaccine response following its simultaneous application with BCG 1st report.
    Zykov MP; Raphaelskaya TI
    Z Erkr Atmungsorgane; 1981; 156(3):203-11. PubMed ID: 7293275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccine 2005-2006.
    Med Lett Drugs Ther; 2005 Oct; 47(1220):85-7. PubMed ID: 16264371
    [No Abstract]   [Full Text] [Related]  

  • 16. Influenza vaccine, 1998-1999.
    Med Lett Drugs Ther; 1998 Sep; 40(1035):91-2. PubMed ID: 9760949
    [No Abstract]   [Full Text] [Related]  

  • 17. [Methodologic studies on the development of an influenza dispensary for risk patients with cardiovascular diseases].
    Sinnecker H; Woratz G; Müller D; Grimm J; Bog R; Müller EM; Hajduk F
    Z Gesamte Hyg; 1984 Jul; 30(7):372-6. PubMed ID: 6485400
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influenza virus vaccines].
    Schell KR
    Schweiz Med Wochenschr; 1980 Apr; 110(14):510-22. PubMed ID: 6154970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection bias in evaluating of influenza vaccine effectiveness: a lesson from an observational study of elderly nursing home residents.
    Fukushima W; Hayashi Y; Mizuno Y; Suzuki K; Kase T; Ohfuji S; Fujieda M; Maeda A; Hirota Y
    Vaccine; 2008 Nov; 26(50):6466-9. PubMed ID: 18582520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.
    Herrera GA; Iwane MK; Cortese M; Brown C; Gershman K; Shupe A; Averhoff F; Chaves SS; Gargiullo P; Bridges CB
    Vaccine; 2007 Jan; 25(1):154-60. PubMed ID: 17064823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.